PreveCeutical Medical (XCNQ:PREV) 3-Year EBITDA Growth Rate : 34.10% (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is PreveCeutical Medical 3-Year EBITDA Growth Rate?

PreveCeutical Medical's EBITDA per Share for the three months ended in Sep. 2023 was C$0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 34.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 45.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of PreveCeutical Medical was 56.30% per year. The lowest was -108.00% per year. And the median was 34.10% per year.

Competitive Comparison of PreveCeutical Medical's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, PreveCeutical Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PreveCeutical Medical's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's 3-Year EBITDA Growth Rate falls into.

PreveCeutical Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PreveCeutical Medical (XCNQ:PREV) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PreveCeutical Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PreveCeutical Medical (XCNQ:PREV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (XCNQ:PREV) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

PRVCF:USA 18H:Germany

Address

885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6

Website

https://www.preveceutical.com

PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. It is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical (XCNQ:PREV) Headlines

No Headlines